SC
IRWD icon

Schubert & Co’s Ironwood Pharmaceuticals IRWD Stock Holding History

Schubert & Co’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-74
Closed -$779 – 761
2023
Q1 		$779 Buy
74
+23
+45% +$258 ﹤0.01% 1294
2022
Q4 		$632 Sell
51
-6
-11% -$68 ﹤0.01% 1327
2022
Q3 		$1K Sell
57
-23
-29% -$261 ﹤0.01% 1132
2022
Q2 		$1K Buy
80
+59
+281% +$695 ﹤0.01% 1145
2022
Q1 		$0 Buy
21
+3
+17% +$34 ﹤0.01% 1198
2021
Q4 		$0 Buy
+18
New +$221 ﹤0.01% 1141

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Schubert & Co's IRWD Position: Q2 2023 in Review

Schubert & Co sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2023, closing a stake of 74 shares — an estimated $779 sold.

Schubert & Co first reported a position in IRWD in Q4 2021 and held it in 6 quarters. The position peaked at $1K in Q3 2022. 252 funds tracked by Wall St. Rank hold IRWD as of Q2 2023.

  • Schubert & Co reported no remaining Ironwood Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 74 Ironwood Pharmaceuticals shares in Q2 2023, an estimated $779.
  • Schubert & Co first reported a position in Ironwood Pharmaceuticals in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Ironwood Pharmaceuticals position peaked at $1K in Q3 2022.
  • 252 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.